ALLERGY (COPENHAGEN)

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

GB

tipo

journal

publicação venue de

IgG memory B cells expressing IL4R and FCER2 are associated with atopic diseases. 78:752-766. 2023-01-01
Different phenotypes of drug-induced anaphylaxis-Data from the European Anaphylaxis Registry. 78:1615-1627. 2023-01-01
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. 78:2232-2254. 2023-01-01
Rhinitis associated with asthma is distinct from rhinitis alone: The hypothesis. 00:1-1203. 2023-01-01
Adrenaline autoinjector is underprescribed in typical cold urticaria patients. 00:1-2229. 2022-01-01
Allergic and hypersensitivity conditions in non¿specialist care: Flow¿diagrams to support clinical practice. 14:100649. 2022-01-01
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air real-world data. epub:epub. 2022-01-01
Comparison of rhinitis treatments using -air® data and considering the minimal important difference. 77:3002-3014. 2022-01-01
Consistent trajectories of rhinitis control and treatment in 16,177-weeks: The -air® longitudinal study. epub:epub. 2022-01-01
Development and validation of combined symptom-medication scores for allergic rhinitis*. epub:epub. 2022-01-01
Presentation of airway and general symptoms in Covid¿19 caused by dominant SARS¿CoV¿2 variants: a follow¿up on ARIA consensus. 00:1-5. 2022-01-01
Risk factors for systemic reactions in typical cold urticaria: Results from the COLD-CE study. 77:2185-2199. 2022-01-01
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update. 15:100627. 2022-01-01
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.. 76:168-190. 2021-01-01
Anaphylaxis during skin prick test with aeroallergen extract: Case report. 76:442-443. 2021-01-01
Asthmatic patients and COVID-19: Different disease course?. 76:963-965. 2021-01-01
Characteristics of patients with severe allergic asthma according to atopic multimorbidity. 76:444-445. 2021-01-01
Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort. 76:1765-1775. 2021-01-01
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2 LEN consensus.. 76:2354-2366. 2021-01-01
Differentiation of COVID¿19 signs and symptoms from allergic rhinitis and common cold¿ An ARIA¿EAACI¿GA LENconsensus. 76:1-2366. 2021-01-01
Effects of pregnancy on chronic urticaria: Results of the PREG-CU UCARE study. 76:3133-3144. 2021-01-01
Impact of early life geohelminths on wheeze, asthma and atopy in Ecuadorian children at 8 years. xx:all.14821. 2021-01-01
Management of anaphylaxis due to COVID-19 vaccines in the elderly.. 1:1-2964. 2021-01-01
The International EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. 75:1-766. 2021-01-01
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice. 1:1-190. 2020-01-01
ARIA‐EAACI statement on asthma and COVID‐19 (June 2, 2020). 00:1-697. 2020-01-01
Arginase inhibitors: An alternative in treatment of obese asthma?. 75:1525-1526. 2020-01-01
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. epub:all.14453-epub. 2020-01-01
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. 6:1-3. 2020-01-01
Correlation between work impairment, scores of rhinitis severity and asthma using the MASK¿air App. 00:1-10. 2020-01-01
Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence. 4:1-2119. 2020-01-01
Genetic Variants Associated with T¿Cell Mediated Cutaneous Adverse Drug Reactions: A Prisma¿Compliant Systematic Review - an EAACI Position Paper. 75:1069-1098. 2020-01-01
Global implementation of the world health organization?s international classification of diseases (ICD)¿11: the allergic and hypersensitivity conditions model. 75:2206-2218. 2020-01-01
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement. 75:1546-1554. 2020-01-01
Hypersensitivities following allergen antigen recognition by unconventional T cells. 1:all.14279. 2020-01-01
In vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy. .:.. 2020-01-01
Influence of emotional stress on clinical presentation of chronic urticaria patient. 75:471-471. 2020-01-01
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. 75:2440-2444. 2020-01-01
N¿terminal peptide deletion influences immunological and structural features of Blo t 5. 71:1-15. 2020-01-01
Presence of angioedema in chronic urticaria and montelukast response. 75:199-199. 2020-01-01
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry. 75:901-910. 2020-01-01
The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens. 75:2219-2228. 2020-01-01
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. 75:1-830. 2020-01-01
Vasculitis in patients with chronic urticaria or autoimmune disease. 75:499-499. 2020-01-01
n vitro NLRP3 inflammasome activation assay assists diagnosis of genetically negative CAPS patients and guides anti-IL1 therapy [Internet]. 75:427. 2020-01-01

tem uma área de assunto

publisher

Wiley-Blackwell

is open access

False invalid format

is in DOAJ

False invalid format